Tagged biotechnology
Press Release
CytoImmune Therapeutics Announces Publication Demonstrating Platelet-Derived Growth Factor D Signaling Activates Natural Killer (NK) Cells and Enhances NK Cell Survival
A PNAS study demonstrates platelet-derived growth factor D (PDGF-D) binding to PDGF receptor-beta (PDGFRβ) activates NK cells to enhance interleukin (IL)-15-mediated NK cell survival. City of Hope research suggests that the selective introduction of PDGF signaling in NK cells by IL-15 should benefit NK cell expansion and persistence and/or enhance effector function in NK cell-based immunotherapies. Read More
Press Release
CytoImmune Appoints Distinguished Cell Therapy and Chemistry, Manufacturing and Controls Expert as Puerto Rico-Based Chief Operating Officer
The clinical-stage biotech CytoImmune Therapeutics welcomes Puerto Rico native and biochemistry and molecular biology expert José Eduardo Vidal, Ph.D., to lead the cellular and virus manufacturing capabilities. Read More
Press Release
The Ionic Liquids Market projected to surpass $4.5 billion by 2027, Says Global Market Insights Inc.
Growing awareness among consumers and the manufacturing sector regarding environmental pollution and the need for sustainable practices should drive ionic liquids demand as a green solvent with low toxicity, Says this report. Read More
Press Release
5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021
There is free registration for all interested attendees: http://tinyurl.com/SDDS2021. Co-Sponsored by the Stanford Cardiovascular Institute, Stanford Cancer Institute, Stanford Cardiovascular Health, and many others. Read More
Press Release
AG Scientific, Inc. Announces Agreement of Acquisition by RPI
AG Scientific, Inc. is thrilled to announce their recent acquisition by RPI. Effective immediately AG Scientific, Inc. will continue operations as AG Scientific Holdings, LLC — a subsidiary of RPI. AG Scientific has agreed to be acquired for an undisclosed amount. Read More
Press Release
As Houston Becomes an Appealing Destination for the Life Sciences Sector, NAI Partners' Life Sciences & Healthcare Team Continues to Assist National Firms Expanding to Texas
Affordability, amiable climate, and booming medical center affirm the Greater Houston Area's reputation as among the most appealing destinations in the United States for the Life Sciences product type Read More
Press Release
AlgaEnergy and Laboratoire M2 Sign Global Strategic Partnership Agreements for Distribution and Product Development
AlgaEnergy will become exclusive worldwide distributor of Laboratoire M2 biocontrol products and will collaborate with the Quebec company's scientists on new disease-control products for agriculture Read More
Press Release
Serán Bioscience Announces Investment by Vivo Capital
A majority investment by Vivo Capital, a healthcare investment firm headquartered in Silicon Valley, will fund the expansion of Serán's service offering, the doubling of clean room capacity by year-end, and the development and construction a new commercial scale cGMP manufacturing facility by the end of 2022. Read More
Press Release
First Rapid Corona Antigen Test Approved for Clinical Study in Germany
The health tech company Digital Diagnostics AG from Mainz, Germany, has received approval for clinical trials from a German ethics committee and the Federal Institute for Drugs and Medical Devices (BfArM). This is a crucial regulatory step in the ongoing approval process for the Digid Cantisense™ SARS-CoV-2 test in Germany. The aim of the clinical trials is to demonstrate the reliability of the new technology in comparison with conventional PCR tests. The new test is particularly suitable for access control at airports or at large-scale event Read More
Press Release
LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery
OcuRing™ is a novel drug delivery platform for cataract surgery with potential to eliminate the need for postoperative topical eye drops. $3M DoD award will fund IND-enabling toxicology and manufacturing activities. LayerBio plans to develop OcuRing™ products for multiple cataract surgery-related indications. Read More
Press Release
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
At the Helmholtz Centre for Infection Research (HZI), scientists have succeeded for the first time in detecting SARS-CoV-2 viruses using the revolutionary Cantisense™ technology from Digital Diagnostics AG. Application for approval of the Digid Cantisense™ SARS-CoV-2 Test by the FDA has been submitted. Delivery of the first point-of-care tests is planned for July. Read More
Press Release
